Pharmaceutical giant Pfizer Inc. has agreed this week to acquire Arena Pharmaceuticals Inc. in a deal valued at roughly $6.7 billion. The acquisition of San Diego-based Arena brings potential therapies to Pfizer that target immuno-inflammatory diseases. Pfizer will pay $100 a share in an all-cash transaction for Arena and its assets in gastroenterology, dermatology and … Continue reading “Pfizer Agrees to Buy Arena Pharmaceuticals for $6.7B”
